Cargando…
Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination
The immune response is known to wane after vaccination with BNT162b2, but the role of age, morbidity and body composition is not well understood. We conducted a cross-sectional study in long-term care facilities (LTCFs) for the elderly. All study participants had completed two-dose vaccination with...
Autores principales: | Delbrück, Marla, Hoehl, Sebastian, Toptan, Tuna, Schenk, Barbara, Grikscheit, Katharina, Metzler, Melinda, Herrmann, Eva, Ciesek, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261435/ https://www.ncbi.nlm.nih.gov/pubmed/35821813 http://dx.doi.org/10.3389/fragi.2022.883724 |
Ejemplares similares
-
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
por: Kohmer, Niko, et al.
Publicado: (2023) -
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
por: Wilhelm, Alexander, et al.
Publicado: (2022) -
Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination
por: Grikscheit, Katharina, et al.
Publicado: (2022) -
Decline of immune humoral response after BNT162b2 vaccine
por: Ferri, Sonia, et al.
Publicado: (2022) -
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
por: Toptan, Tuna, et al.
Publicado: (2021)